In addition, K5+ subpopulation of cells have been identified in ER+ PR+ luminal breast cancers [23, 24] and are increased in patients whose luminal breast cancers develop resistance to endocrine treatment and chemotherapy [25, 26]. Here, KRT5 is linked to breast cancer.